Effect of omalizumab on inflammatory markers in COVID-19: an exploratory analysis of the COVID-19 immunologic antiviral therapy with omalizumab (CIAO) trial.

Saved in:
Bibliographic Details
Title: Effect of omalizumab on inflammatory markers in COVID-19: an exploratory analysis of the COVID-19 immunologic antiviral therapy with omalizumab (CIAO) trial.
Authors: Prosty C; Faculty of Medicine, McGill University, Montreal, QC, Canada., Le M; Division of Dermatology, Department of Medicine, McGill University, Montreal, QC, Canada., Lu Y; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, QC, Canada., Khoury L; Faculty of Medicine, McGill University, Montreal, QC, Canada., Cormier M; Division of Respiratory Medicine, Department of Medicine, McGill University, Montreal, QC, Canada., Cheng MP; Division of Infectious Diseases, Department of Medicine, McGill University, Montreal, QC, Canada., Fowler R; Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada., Murthy S; Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada., Tsang JL; Niagara Health Knowledge Institute, Niagara Health, St. Catharines, ON, Canada., Lejtenyi D; Division of Allergy, Immunology and Dermatology, Department of Pediatrics, Montreal Children's Hospital, McGill University, Montreal, QC, Canada., Ben-Shoshan M; Division of Allergy, Immunology and Dermatology, Department of Pediatrics, Montreal Children's Hospital, McGill University, Montreal, QC, Canada., Rahme E; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, QC, Canada., Golchi S; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, QC, Canada., Dendukuri N; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, QC, Canada., Lee TC; Division of Infectious Diseases, Department of Medicine, McGill University, Montreal, QC, Canada., Netchiporouk E; Faculty of Medicine, McGill University, Montreal, QC, Canada.
Source: Frontiers in medicine [Front Med (Lausanne)] 2024 Nov 19; Vol. 11, pp. 1437322. Date of Electronic Publication: 2024 Nov 19 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN: 2296-858X (Print) Linking ISSN: 2296858X NLM ISO Abbreviation: Front Med (Lausanne) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2296-858X
DOI:10.3389/fmed.2024.1437322